论文信息 - Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".

Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".

We appreciate the comments by Drs Wang and Zhao regarding our recent article on atrial fibrillation (AF) in patients with hypertrophic cardiomyopathy (HCM).1 Distinctive from ischemic heart disease, inappropriate implantable cardioverter-defibrillator therapy in HCM appears to be unassociated with cardiovascular morbidity or mortality or transformation to heart failure deterioration.2–5 Specifically, 19 …

B. Maron | M. Maron | E. Rowin

[1] G. Boriani,et al. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators , 2018, Circulation. Arrhythmia and electrophysiology.

[2] M. Link,et al. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy , 2017, Circulation.

[3] B. Maron,et al. Interaction of Adverse Disease Related Pathways in Hypertrophic Cardiomyopathy. , 2017, The American journal of cardiology.

[4] L. Jordaens,et al. Outcome and Complications After Implantable Cardioverter Defibrillator Therapy in Hypertrophic Cardiomyopathy: Systematic Review and Meta-Analysis , 2012, Circulation. Heart failure.

[5] M. Link,et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. , 2007, JAMA.